Comparison of naftopidil and silodosin in the treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia : a randomized, crossover study

We compared the efficacy, safety, and patient preferences for two α1-adrenoceptor (AR) antagonists with different affinity for AR subtypes, naftopidil (Naf) and silodosin (Silo), for the treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia (male LUTS/BPH). New...

Description complète

Détails bibliographiques
Publié dans:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 58(2012), 12 vom: 28. Dez., Seite 671-8
Auteur principal: Masuda, Mitsunobu (Auteur)
Autres auteurs: Jinza, Shin-ichirou, Masuko, Hiroshi, Asakura, Tomoyuki, Hashiba, Takafumi
Format: Article
Langue:Japanese
Publié: 2012
Accès à la collection:Hinyokika kiyo. Acta urologica Japonica
Sujets:Clinical Trial Comparative Study English Abstract Journal Article Randomized Controlled Trial Adrenergic alpha-Antagonists Indoles Naphthalenes Piperazines silodosin plus... CUZ39LUY82 naftopidil R9PHW59SFN